These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37361278)

  • 21. Economic evaluation of programs against COVID-19: A systematic review.
    Rezapour A; Souresrafil A; Peighambari MM; Heidarali M; Tashakori-Miyanroudi M
    Int J Surg; 2021 Jan; 85():10-18. PubMed ID: 33227532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic Evaluation of Hospital and Community Pharmacy Services.
    Gammie T; Vogler S; Babar ZU
    Ann Pharmacother; 2017 Jan; 51(1):54-65. PubMed ID: 27586430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simulation Modeling for the Economic Evaluation of Population-Based Dietary Policies: A Systematic Scoping Review.
    Emmert-Fees KMF; Karl FM; von Philipsborn P; Rehfuess EA; Laxy M
    Adv Nutr; 2021 Oct; 12(5):1957-1995. PubMed ID: 33873201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical policies: effects of financial incentives for prescribers.
    Rashidian A; Omidvari AH; Vali Y; Sturm H; Oxman AD
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD006731. PubMed ID: 26239041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of international modelling methods to evaluate health economics of colorectal cancer screening: a systematic review protocol.
    Adair O; McFerran E; Owen T; McKee C; Lamrock F; Lawler M
    Syst Rev; 2023 Jan; 12(1):14. PubMed ID: 36707908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of strategies against coronavirus: a systematic review.
    Izadi R; Hatam N; Baberi F; Yousefzadeh S; Jafari A
    Health Econ Rev; 2023 Mar; 13(1):18. PubMed ID: 36933043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Research can be integrated into public health policy-making: global lessons for and from Spanish economic evaluations.
    Trapero-Bertran M; Pokhrel S; Hanney S
    Health Res Policy Syst; 2022 Jun; 20(1):67. PubMed ID: 35717247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques.
    Jesudason T; Rodarte A; Tordrup D; Carias C; Chen YH
    Vaccine; 2023 Aug; 41(36):5221-5232. PubMed ID: 37479614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan P; Edlin R
    J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of routine health information systems to monitor disruptions of coverage of maternal, newborn, and child health services during COVID-19: A scoping review.
    Jackson D; Katwan E; Boehm C; Diaz T
    J Glob Health; 2023 Feb; 13():06002. PubMed ID: 36757820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Public health economics: a systematic review of guidance for the economic evaluation of public health interventions and discussion of key methodological issues.
    Edwards RT; Charles JM; Lloyd-Williams H
    BMC Public Health; 2013 Oct; 13():1001. PubMed ID: 24153037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods for estimating economic benefits of surgical interventions in low-income and middle-income countries: a scoping review.
    Hilla A; Reese V; Nonvignon J; Dolan CB
    BMJ Open; 2020 Dec; 10(12):e039644. PubMed ID: 33268411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation and mental health: sparse past. fertile future?
    Knapp M
    J Ment Health Policy Econ; 1999 Dec; 2(4):163-167. PubMed ID: 11967427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
    Han R; François C; Toumi M
    Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users.
    O'Flaherty M; Lloyd-Williams F; Capewell S; Boland A; Maden M; Collins B; Bandosz P; Hyseni L; Kypridemos C
    Health Technol Assess; 2021 May; 25(35):1-234. PubMed ID: 34076574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cost of Neurodevelopmental Disability: Scoping Review of Economic Evaluation Methods.
    Kularatna S; Jadambaa A; Senanayake S; Brain D; Hawker N; Kasparian NA; Abell B; Auld B; Eagleson K; Justo R; McPhail SM
    Clinicoecon Outcomes Res; 2022; 14():665-682. PubMed ID: 36304697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations.
    Dawoud DM; Soliman KY
    Value Health; 2020 Nov; 23(11):1409-1422. PubMed ID: 33127010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.